The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...
Locality Bank officially completed its de novo period on January 12, 2025, marking a significant milestone and the end of the initial three-year supervisory phase for newly chartered banks, ...
The firm is focusing on specialty chronic therapies like immunotherapy, antibody-drug conjugates, and gene therapy drugs, ...
HIGHLIGHTS Geological and geochemical sampling campaigns designed to guide effective targeting for drill programs in Q2 2025 ...
Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...
HIGHLIGHTS Geological and geochemical sampling campaigns designed to guide effective targeting for drill programs in Q2 2025 ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Barchart on MSN4h
Is This Penny Stock’s 525% Upside Potential an Attainable Goal?A smart investment strategy is to diversify your portfolio with both stable, established companies and growth stocks. Growth ...
As high prices and supply issues drive consumers to alternative markets for GLP-1s, physicians aren’t too interested in using ...
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains.
Medicare, the government-backed program for adults aged 65 and older and those with disabilities, only covers the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback